I'm LongbridgeAI, I can summarize articles.Oscar Health (OSCR) gained 4.53% this week to close at $30.94, outperforming the S&P 500 by about 4.8 percentage points. Trading was choppy but tended higher: the stock opened at $29.51 on Monday, pushed to $30.99 intraday on Wednesday, slipped back to $29.90 on Thursday, then climbed to a high of $31.17 on Friday before settling at $30.94. Weekly amplitude was 7.39%. Average daily volume of 4.22m shares came in about 12% below the median.
The Week
Oscar Health (OSCR) gained 4.53% this week to close at $30.94, outperforming the S&P 500 by about 4.8 percentage points. Trading was choppy but tended higher: the stock opened at $29.51 on Monday, pushed to $30.99 intraday on Wednesday, slipped back to $29.90 on Thursday, then climbed to a high of $31.17 on Friday before settling at $30.94. Weekly amplitude was 7.39%. Average daily volume of 4.22m shares came in about 12% below the median. There was no major company-specific catalyst this week.
Analyst Ratings
Across 11 brokers covering OSCR, 3 rate it overweight, 7 neutral, and 1 underweight, with no buy or sell ratings. The consensus rating is hold, and the consensus target of $35.40 sits about 14.4% above the current $30.94. Targets range from $26.00 to $49.00, pointing to wide dispersion. OSCR ranks 10th out of 21 companies in its industry for analyst rating.
The Week Ahead
Macro releases dominate next week: US S&P Global services PMI final and ISM non-manufacturing PMI land on Monday, followed by international trade and goods trade balance on Tuesday, and EIA crude inventory data on Wednesday. Healthcare sector sentiment could shift with the macro prints. OSCR has no earnings on the calendar, so the sector tape will be the main thing to watch.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.